U.S. News & World Report Explores Antipsychotic Drug Use in Dementia Care
A recent article in US News & World Report explores the use of antipsychotic drugs to treat dementia symptoms in long-term care facilities, including the potential overuse of the drugs to…
Read MoreTips and Advice: Managing Communication Difficulties
As FTD progressively affects areas of the brain that control reading, writing, speaking, and understanding language, communicating with the person diagnosed may become much more difficult. While this can be…
Read MoreAFTD Webinar: The Promise of FTD Research Trials — What Should I Know About Current Drug Studies?
The science of FTD is quickly evolving. While several years ago, there were no experimental treatments for FTD, there are now many medications being tested in clinical trials. Each trial…
Read MoreAFTD Senior Director of Scientific Initiatives Talks About FTD Research on Remember Me Podcast
AFTD Senior Director of Scientific Initiatives Penny Dacks, PhD, discussed the different types of ongoing FTD research and how people living with FTD can get involved on a recent episode…
Read More#FromHopeToAction: AFTD’s 2022 Annual Report
AFTD’s 2022 Annual Report documents progress made bringing hope to action in each area of our mission (research, advocacy, awareness, education and support) during the fiscal year starting July 1,…
Read MoreWorld Health Organization Publishes “Blueprint” for Global Dementia Research
The World Health Organization (WHO) has published a blueprint for dementia research to guide stakeholders around the world in making research efforts as efficient, equitable, and impactful as possible. …
Read More
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)